Core Viewpoint - The company, 开拓药业-B, announced a share buyback by its chairman, Dr. Tong Youzhi, indicating confidence in the company's future and potential for further investment after a quiet period [2][5]. Group 1: Share Buyback Details - Dr. Tong Youzhi plans to buy back approximately 4.7 million shares, representing about 0.9425% of the total issued share capital, at an average price of HKD 2.30 per share, with a total investment of around HKD 10.82 million [2][5]. - The buyback will occur from November 17, 2025, to January 23, 2026, and the price range for the shares will be between HKD 1.89 and HKD 2.81 [2][5]. Group 2: Market Reaction - Following the announcement, the stock price of 开拓药业-B increased by 3.43%, reaching HKD 3.02, with a trading volume of HKD 12.9761 million [2][5]. Group 3: Future Outlook - Dr. Tong expressed confidence in the overall development prospects and commercialization transformation of the company, suggesting potential for further share purchases after the quiet period ending on March 26, 2026 [2][5].
开拓药业-B午后涨超3% 获董事会主席童友之增持470万股公司股份